Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis

BACKGROUND: Circulating microRNA-122 (miR-122) has been recognized as a marker of hepatocellular carcinoma (HCC). The current meta-analysis was performed to quantitatively evaluate the diagnostic performance of circulating miR-122 for HCC. METHODS: Related studies that evaluated the diagnostic perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiao-Fei, Li, Ning, Lin, Dong-Dong, Sun, Li-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139899/
https://www.ncbi.nlm.nih.gov/pubmed/32309434
http://dx.doi.org/10.1155/2020/5353695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139899/
https://www.ncbi.nlm.nih.gov/pubmed/32309434
http://dx.doi.org/10.1155/2020/5353695

Ejemplares similares